137 related articles for article (PubMed ID: 30885634)
1. Pre-administration of low-dose methamphetamine enhances movement and neural activity after high-dose methamphetamine administration in the striatum.
Takeichi T; Hori O; Hattori T; Kiryu K; Zuka M; Kitamura O
Neurosci Lett; 2019 Jun; 703():119-124. PubMed ID: 30885634
[TBL] [Abstract][Full Text] [Related]
2. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.
Killinger BA; Moszczynska A
J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779
[TBL] [Abstract][Full Text] [Related]
3. Methamphetamine changes NMDA and AMPA glutamate receptor subunit levels in the rat striatum and frontal cortex.
Simões PF; Silva AP; Pereira FC; Marques E; Milhazes N; Borges F; Ribeiro CF; Macedo TR
Ann N Y Acad Sci; 2008 Oct; 1139():232-41. PubMed ID: 18991869
[TBL] [Abstract][Full Text] [Related]
4. Disparity in the temporal appearance of methamphetamine-induced apoptosis and depletion of dopamine terminal markers in the striatum of mice.
Zhu JP; Xu W; Angulo JA
Brain Res; 2005 Jul; 1049(2):171-81. PubMed ID: 16043139
[TBL] [Abstract][Full Text] [Related]
5. Methamphetamine self-administration is associated with persistent biochemical alterations in striatal and cortical dopaminergic terminals in the rat.
Krasnova IN; Justinova Z; Ladenheim B; Jayanthi S; McCoy MT; Barnes C; Warner JE; Goldberg SR; Cadet JL
PLoS One; 2010 Jan; 5(1):e8790. PubMed ID: 20098750
[TBL] [Abstract][Full Text] [Related]
6. Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposure.
McFadden LM; Vieira-Brock PL; Hanson GR; Fleckenstein AE
Neuropharmacology; 2015 Jun; 93():146-54. PubMed ID: 25645392
[TBL] [Abstract][Full Text] [Related]
7. Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure.
McFadden LM; Hadlock GC; Allen SC; Vieira-Brock PL; Stout KA; Ellis JD; Hoonakker AJ; Andrenyak DM; Nielsen SM; Wilkins DG; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2012 Feb; 340(2):295-303. PubMed ID: 22034657
[TBL] [Abstract][Full Text] [Related]
8. Methamphetamine oxidative stress, neurotoxicity, and functional deficits are modulated by nuclear factor-E2-related factor 2.
Ramkissoon A; Wells PG
Free Radic Biol Med; 2015 Dec; 89():358-68. PubMed ID: 26427884
[TBL] [Abstract][Full Text] [Related]
9. Detection of methamphetamine neurotoxicity in forensic autopsy cases.
Kitamura O
Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S63-5. PubMed ID: 19269222
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological activation of the neurotensin receptor 1 abrogates the methamphetamine-induced striatal apoptosis in the mouse brain.
Liu Q; Hazan A; Grinman E; Angulo JA
Brain Res; 2017 Mar; 1659():148-155. PubMed ID: 28130052
[TBL] [Abstract][Full Text] [Related]
11. Distinct gene alterations between Fos-expressing striatal and thalamic neurons after withdrawal from methamphetamine self-administration.
Li X; Davis IR; Lofaro OM; Zhang J; Cimbro R; Rubio FJ
Brain Behav; 2019 Sep; 9(9):e01378. PubMed ID: 31364821
[TBL] [Abstract][Full Text] [Related]
12. Changes in the neuronal glutamate transporter EAAT3 in rat brain after exposure to methamphetamine.
Kerdsan W; Thanoi S; Nudmamud-Thanoi S
Basic Clin Pharmacol Toxicol; 2012 Oct; 111(4):275-8. PubMed ID: 22540959
[TBL] [Abstract][Full Text] [Related]
13. Methamphetamine withdrawal induces activation of CRF neurons in the brain stress system in parallel with an increased activity of cardiac sympathetic pathways.
García-Carmona JA; Georgiou P; Zanos P; Bailey A; Laorden ML
Naunyn Schmiedebergs Arch Pharmacol; 2018 Apr; 391(4):423-434. PubMed ID: 29383398
[TBL] [Abstract][Full Text] [Related]
14. Induction of striatal pre- and postsynaptic damage by methamphetamine requires the dopamine receptors.
Xu W; Zhu JP; Angulo JA
Synapse; 2005 Nov; 58(2):110-21. PubMed ID: 16088948
[TBL] [Abstract][Full Text] [Related]
15. Methamphetamine-induced cell death: selective vulnerability in neuronal subpopulations of the striatum in mice.
Zhu JP; Xu W; Angulo JA
Neuroscience; 2006 Jun; 140(2):607-22. PubMed ID: 16650608
[TBL] [Abstract][Full Text] [Related]
16. Methamphetamine-induced changes in the object recognition memory circuit.
Reichel CM; Ramsey LA; Schwendt M; McGinty JF; See RE
Neuropharmacology; 2012 Feb; 62(2):1119-26. PubMed ID: 22115899
[TBL] [Abstract][Full Text] [Related]
17. Histological evidence supporting a role for the striatal neurokinin-1 receptor in methamphetamine-induced neurotoxicity in the mouse brain.
Yu J; Wang J; Cadet JL; Angulo JA
Brain Res; 2004 May; 1007(1-2):124-31. PubMed ID: 15064143
[TBL] [Abstract][Full Text] [Related]
18. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
Bjorklund NL; Sorg BA; Schenk JO
Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
[TBL] [Abstract][Full Text] [Related]
19. From dysregulated microRNAs to structural alterations in the striatal region of METH-injected rats.
Chavoshi H; Boroujeni ME; Abdollahifar MA; Amini A; Tehrani AM; Moghaddam MH; Norozian M; Farahani RM; Aliaghaei A
J Chem Neuroanat; 2020 Nov; 109():101854. PubMed ID: 32795519
[TBL] [Abstract][Full Text] [Related]
20. Striatal Reinnervation Process after Acute Methamphetamine-Induced Dopaminergic Degeneration in Mice.
Granado N; Ares-Santos S; Tizabi Y; Moratalla R
Neurotox Res; 2018 Oct; 34(3):627-639. PubMed ID: 29934756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
